Startpage

Novel treatments to help patients with central nervous system disorders

News

  • 2014-05-12
    - Läkemedelsstudie startar i Sverige med BAN2401 i tidiga Alzheimerpatienter
    Read more »
  • 2014-05-05
    - BioArctic´s new facilities inaugurated
    Read more »
  • 2014-03-05
    - Biogen Idec invests together with Eisai in BioArctic´s antibody BAN2401 for treatment of Alzheimer´s disease
    Read more »
  • 2014-02-03
    - Media News (Swedish) Life Science Sweden: BioArctic designar studien efterhand
    Read more »
  • 2014-01-21
    - US patent issued for protofibril-binding antibodies for treatment and diagnostics of Parkinson's Disease, Dementia with Lewy Bodies and other Alpha-Synucleinopathies
    Read more »

Technology

iStock_000016517933Large

Antibodies targeting toxic proteins

R&D

iStock_000016548274Large

First drug candidate in development for Alzheimer’s disease

Therapeutic Area

puffimg3

CNS disorders